Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hopefully, he has a mild case and can still work from home
Must have been someone trying to spoof the market!
Looks like we're heading for a year high on volume, one more number to go.
They're moving straight to human trials with drugs that are already approved so this could be a quick process. "As an initial step in the research program, Lexaria intends to conduct a pilot human pharmacokinetic exploratory study in healthy volunteers of three anti-retroviral drugs that have previously been studied against other coronavirus strains,..."
NO, no ,no. Shhh! Let's make this our little secret.
They're not talking about vaccines, didn't you read the news release?
Antiretroviral Drugs not vaccines.
And Lexaria has long said that DehydraTECH could be used to deliver multiple kinds of APIs specifically fat-soluble drugs.
"...in collaboration with leading laboratories in Canada and the United States,..."
I would love to know which ones and how many.
If Altria received the results on Jan. 15 then they need to make their decision by April 15, 90 days from when they received it.
They aren't doing the bottling but they are trying to license their own facility to produce the powders for (co-packer)themselves and to wholesale the powder.
Yes, Stockman, I remember discussions about the possibility of delivering vaccines across the blood-brain barrier. Lexaria has been working with the National Research Council of Canada for 3 years now and very little has actually been reported. I believe that there's a lot more going on at the NRC, beyond the original master collaborative agreement results and the work for Altria. Multiple patents to come under numerous categories?
https://thedeepdive.ca/valens-first-to-canadian-market-with-ready-to-drink-cannabis-beverage/
I wonder if they've solved the problem of the cannabis molecules bonding to the polyethylene. Both their CBD and their THC drinks are bottled in PET (Plastic).
Great news! Some were pounding the table for revenue! 100,000 units shipped and that's just the start. Great work Lexaria! This powder manufacturing plant is going to be a cash cow. We need the same in Canada and I think it's coming.
http://cloud.stockwatch.com/News/Sedardoc.pdf?docid=4493100
Hill Street Beverage loses $882,658 in Q2 2020
290 is an 'odd lot' so you can expect some delay having it filled. Bid 500 shares and there shouldn't be a problem.
The presentation appears to be a very old one probably from some time in 2017. We're paying an IR company to publish an old presentation? WTF?
Yes Bunka included this because of Canopy's and others woes.
'Certain types of packaging, such as polystyrene, can also absorb between 60% and 100% of the THC within (LINK), if the consumer products have not been stabilized such as is possible with DehydraTECH. Consumers have legitimate concerns about inventories of hemp or cannabis oil or plant matter being used to create products, and whether their potency is as advertised.'
It is interesting stockman! WEED paid C$430 million for EBBU who was supposed to have this great proprietory tech. for infusing beverages with cannabis. It turns out their tech was just a variation on known emulsification tech. and the US Patent office wouldn't issue EBBU any patents. And now we see how it works, at least in aluminum cans. I think Canopy may have to write down almost their complete investment in EBBU and also all the canned inventory is a total loss. Anybody want to buy a barely used canning plant? Or perhaps Canopy would like to license a technology that works and has been through extensive stability and safety testing at the National Research Council of Canada.
Whoops! Should have gone with Lexaria instead of grossly overpaying for EBBU to gain an unpatentable technology that sucks!
https://ca.finance.yahoo.com/news/cans-suck-the-thc-buzz-out-of-pot-drinks-where-does-that-leave-canopy-growth-131708432.html
Early 2020 was his latest timeline for Altria news
I'm curious as to why they don't say who is getting the options.
A devastating short report on Canopy Growth can be downloaded here: https://smartmoneygains.com/sector-watch/canopy-growths-smoke-and-mirrors/?fbclid=IwAR1Q6rTpxBOvhSFnKsO8XAzCW36sUu5JlmRoEoJuUbR7yH3a1pGYRvNg9yE
Oh, do tell! What's the question?
on! is now available in 15,000 stores nationally, including 3 of the top 5 chains for smokeless volume.
Helix expects to begin manufacturing on! at the Richmond Manufacturing Center in first-quarter 2020.
Just read through Altria's financials, no hints in there!
It will be interesting to see what if any forward-looking statements Altria makes tomorrow during earnings report in regards to progress towards a smokeless future.
Altria is set to release their earnings on Jan 30 so maybe we'll hear something re: the Lexaria deal shortly after that.
Here is a very detailed analysis of MOU.
https://seekingalpha.com/article/4319256-altria-why-next-decade-will-make-break-company?utm_medium=email&utm_source=seeking_alpha
I'm not sure why, as he doesn't seem to have a production facility or a co-packer to make cannabis beverages, and I haven't heard of him applying to Health Canada for a license to produce anything. He's missed the boat and I'm a bag-holder.
BEER up 25% this morning. +.02 cents
Some of us here are older and we need our 'quiet' time. LOL
Yes the OS is 80,720,879, not fully diluted.
Chris Bunka owns over 13 million shares.
We know that the Altria/Lexaria/NRC workgroup is testing various product formats, under investigation at the National Research Council should be powders, tablets/caps, lozenges and nicotine pouches e.g. On! All in several dosages.
https://www.marketwatch.com/story/altria-stock-boosted-by-news-of-acquisition-of-nicotine-pouch-business-on-2019-06-03
Altria is going to use DehydraTECH to make their pouches the best on the market, with the lowest manufacturing cost.
Nice close in Canuckland .70 up .09, but volume low.
This explains a lot.
Lexaria’s workgroup, including extensive ongoing R&D performed by Canada’s National Research Council on our behalf, continues to work closely with Altria to determine the appropriateness of the DehydraTECH technology for potential use in the global tobacco industry, via several product formats currently under investigation. Lexaria is making important, significant progress in its goal of achieving reduced-risk methods of nicotine delivery.
https://www.lexariabioscience.com/news/lexaria-bioscience-ceo-discusses-strategic-outlook/
67,000 bid @ .65 now!
Bids pilling up on Canadian side, 42,500 bid at .65
Ask now .70 in Great White North, only 1000 shares.
There is no category for drink powders it seems. Yes, Hill Street is supposed to make the powders in Canada, whether it will be branded as ChrgD+ I don't know.